Pharmaceutical Manufacturing Market Size, Share, Trends, Growth Outlook

Pharmaceutical Manufacturing Market is estimated to increase at a growth rate of 6.9% CAGR over the forecast period from 2024 to 2030.

The global Pharmaceutical Manufacturing Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Molecule (Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules)), By Drug Development (In-house, Outsource), By Formulation (Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Others), By Route of Administration (Oral, Topical, Parenteral, Inhalations, Others), By Therapy Area (Cardiovascular Diseases, Pain, Diabetes, Cancer, Respiratory Diseases, Others), By Prescription (Prescription Medicines, Over-the-counter (OTC) Medicines), By Age group (Children & Adolescents, Adults, Geriatric), By Sales Channel (Retail, Non-retail).

An introduction to Pharmaceutical Manufacturing Market in 2024

Driving the production of medications, the Pharmaceutical Manufacturing Market encompasses the entire process of drug development, formulation, production, packaging, and distribution. This market involves various stages, including synthesis of active pharmaceutical ingredients (APIs), formulation development, manufacturing of dosage forms (tablets, capsules, injections, etc.), quality control testing, and packaging for distribution. The pharmaceutical manufacturing market is crucial for ensuring the availability of safe, effective, and high-quality medications for patients worldwide. Factors contributing to its growth include advancements in manufacturing technologies, increasing demand for pharmaceuticals due to rising healthcare needs, and efforts to improve production efficiency and quality control.

Pharmaceutical Manufacturing market Trend: Increasing Adoption of Advanced Manufacturing Technologies

The pharmaceutical manufacturing market is witnessing a significant trend towards the adoption of advanced manufacturing technologies such as continuous manufacturing, robotics, and artificial intelligence. These technologies streamline production processes, enhance efficiency, ensure quality control, and reduce manufacturing costs, thus driving growth and innovation within the industry.

Pharmaceutical Manufacturing market Driver: Rising Demand for Personalized Medicine

A key driver in the pharmaceutical manufacturing market is the escalating demand for personalized medicine. With advancements in genomics and biotechnology, there is a growing understanding of individual variations in disease susceptibility and drug response. This has led to a shift towards tailored therapies, driving pharmaceutical companies to invest in manufacturing capabilities that support the production of personalized medicines, thereby stimulating market expansion.

Pharmaceutical Manufacturing market Opportunity: Expansion into Emerging Markets

An enticing opportunity for pharmaceutical manufacturers lies in expanding operations into emerging markets. These regions exhibit increasing healthcare expenditures, improving regulatory environments, and growing demand for pharmaceutical products due to rising population, urbanization, and lifestyle changes. By establishing a presence in these markets, companies can access new revenue streams, diversify their customer base, and capitalize on the untapped potential for growth.

Pharmaceutical Manufacturing Market Market Segmentation

By Molecule
Biologics & Biosimilars (Large Molecules)
-Monoclonal Antibodies
-Vaccines
-Cell & Gene Therapy
-Others
Conventional Drugs (Small Molecules)
By Drug Development
In-house
Outsource
By Formulation
Tablets
Capsules
Injectable
Sprays
Suspensions
Powders
Others
By Route of Administration
Oral
Topical
Parenteral
Inhalations
Others
By Therapy Area
Cardiovascular Diseases (CVDs)
Pain
Diabetes
Cancer
Respiratory Diseases
Others
By Prescription
Prescription Medicines
Over-the-counter (OTC) Medicines
By Age Group
Children & Adolescents
Adults
Geriatric
By Sales Channel
Retail
Non-retail

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Pharmaceutical Manufacturing Market Companies

AbbVie Inc
AstraZeneca
Catalent Pharma Solutions
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
FUJIFILM Diosynth Biotechnologies U.S.A. Inc
GlaxoSmithKline plc
Johnson & Johnson
Jubilant Pharmova Ltd
Lonza
Merck & Co. Inc
Novartis AG
Pfizer Inc
Samsung Biologics
Sanofi SA
Thermo Fisher Scientific Inc
Wuxi Apptec

Reasons to Buy the Pharmaceutical Manufacturing Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Pharmaceutical Manufacturing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Pharmaceutical Manufacturing Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Pharmaceutical Manufacturing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Pharmaceutical Manufacturing Market Size Outlook, $ Million, 2021 to 2030
3.2 Pharmaceutical Manufacturing Market Outlook by Type, $ Million, 2021 to 2030
3.3 Pharmaceutical Manufacturing Market Outlook by Product, $ Million, 2021 to 2030
3.4 Pharmaceutical Manufacturing Market Outlook by Application, $ Million, 2021 to 2030
3.5 Pharmaceutical Manufacturing Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Pharmaceutical Manufacturing Industry
4.2 Key Market Trends in Pharmaceutical Manufacturing Industry
4.3 Potential Opportunities in Pharmaceutical Manufacturing Industry
4.4 Key Challenges in Pharmaceutical Manufacturing Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Pharmaceutical Manufacturing Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Pharmaceutical Manufacturing Market Outlook by Segments
7.1 Pharmaceutical Manufacturing Market Outlook by Segments, $ Million, 2021- 2030
By Molecule
Biologics & Biosimilars (Large Molecules)
-Monoclonal Antibodies
-Vaccines
-Cell & Gene Therapy
-Others
Conventional Drugs (Small Molecules)
By Drug Development
In-house
Outsource
By Formulation
Tablets
Capsules
Injectable
Sprays
Suspensions
Powders
Others
By Route of Administration
Oral
Topical
Parenteral
Inhalations
Others
By Therapy Area
Cardiovascular Diseases (CVDs)
Pain
Diabetes
Cancer
Respiratory Diseases
Others
By Prescription
Prescription Medicines
Over-the-counter (OTC) Medicines
By Age Group
Children & Adolescents
Adults
Geriatric
By Sales Channel
Retail
Non-retail

8 North America Pharmaceutical Manufacturing Market Analysis and Outlook To 2030
8.1 Introduction to North America Pharmaceutical Manufacturing Markets in 2024
8.2 North America Pharmaceutical Manufacturing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Pharmaceutical Manufacturing Market size Outlook by Segments, 2021-2030
By Molecule
Biologics & Biosimilars (Large Molecules)
-Monoclonal Antibodies
-Vaccines
-Cell & Gene Therapy
-Others
Conventional Drugs (Small Molecules)
By Drug Development
In-house
Outsource
By Formulation
Tablets
Capsules
Injectable
Sprays
Suspensions
Powders
Others
By Route of Administration
Oral
Topical
Parenteral
Inhalations
Others
By Therapy Area
Cardiovascular Diseases (CVDs)
Pain
Diabetes
Cancer
Respiratory Diseases
Others
By Prescription
Prescription Medicines
Over-the-counter (OTC) Medicines
By Age Group
Children & Adolescents
Adults
Geriatric
By Sales Channel
Retail
Non-retail

9 Europe Pharmaceutical Manufacturing Market Analysis and Outlook To 2030
9.1 Introduction to Europe Pharmaceutical Manufacturing Markets in 2024
9.2 Europe Pharmaceutical Manufacturing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Pharmaceutical Manufacturing Market Size Outlook by Segments, 2021-2030
By Molecule
Biologics & Biosimilars (Large Molecules)
-Monoclonal Antibodies
-Vaccines
-Cell & Gene Therapy
-Others
Conventional Drugs (Small Molecules)
By Drug Development
In-house
Outsource
By Formulation
Tablets
Capsules
Injectable
Sprays
Suspensions
Powders
Others
By Route of Administration
Oral
Topical
Parenteral
Inhalations
Others
By Therapy Area
Cardiovascular Diseases (CVDs)
Pain
Diabetes
Cancer
Respiratory Diseases
Others
By Prescription
Prescription Medicines
Over-the-counter (OTC) Medicines
By Age Group
Children & Adolescents
Adults
Geriatric
By Sales Channel
Retail
Non-retail

10 Asia Pacific Pharmaceutical Manufacturing Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Pharmaceutical Manufacturing Markets in 2024
10.2 Asia Pacific Pharmaceutical Manufacturing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Pharmaceutical Manufacturing Market size Outlook by Segments, 2021-2030
By Molecule
Biologics & Biosimilars (Large Molecules)
-Monoclonal Antibodies
-Vaccines
-Cell & Gene Therapy
-Others
Conventional Drugs (Small Molecules)
By Drug Development
In-house
Outsource
By Formulation
Tablets
Capsules
Injectable
Sprays
Suspensions
Powders
Others
By Route of Administration
Oral
Topical
Parenteral
Inhalations
Others
By Therapy Area
Cardiovascular Diseases (CVDs)
Pain
Diabetes
Cancer
Respiratory Diseases
Others
By Prescription
Prescription Medicines
Over-the-counter (OTC) Medicines
By Age Group
Children & Adolescents
Adults
Geriatric
By Sales Channel
Retail
Non-retail

11 South America Pharmaceutical Manufacturing Market Analysis and Outlook To 2030
11.1 Introduction to South America Pharmaceutical Manufacturing Markets in 2024
11.2 South America Pharmaceutical Manufacturing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Pharmaceutical Manufacturing Market size Outlook by Segments, 2021-2030
By Molecule
Biologics & Biosimilars (Large Molecules)
-Monoclonal Antibodies
-Vaccines
-Cell & Gene Therapy
-Others
Conventional Drugs (Small Molecules)
By Drug Development
In-house
Outsource
By Formulation
Tablets
Capsules
Injectable
Sprays
Suspensions
Powders
Others
By Route of Administration
Oral
Topical
Parenteral
Inhalations
Others
By Therapy Area
Cardiovascular Diseases (CVDs)
Pain
Diabetes
Cancer
Respiratory Diseases
Others
By Prescription
Prescription Medicines
Over-the-counter (OTC) Medicines
By Age Group
Children & Adolescents
Adults
Geriatric
By Sales Channel
Retail
Non-retail

12 Middle East and Africa Pharmaceutical Manufacturing Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Pharmaceutical Manufacturing Markets in 2024
12.2 Middle East and Africa Pharmaceutical Manufacturing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Pharmaceutical Manufacturing Market size Outlook by Segments, 2021-2030
By Molecule
Biologics & Biosimilars (Large Molecules)
-Monoclonal Antibodies
-Vaccines
-Cell & Gene Therapy
-Others
Conventional Drugs (Small Molecules)
By Drug Development
In-house
Outsource
By Formulation
Tablets
Capsules
Injectable
Sprays
Suspensions
Powders
Others
By Route of Administration
Oral
Topical
Parenteral
Inhalations
Others
By Therapy Area
Cardiovascular Diseases (CVDs)
Pain
Diabetes
Cancer
Respiratory Diseases
Others
By Prescription
Prescription Medicines
Over-the-counter (OTC) Medicines
By Age Group
Children & Adolescents
Adults
Geriatric
By Sales Channel
Retail
Non-retail

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
AbbVie Inc
AstraZeneca
Catalent Pharma Solutions
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
FUJIFILM Diosynth Biotechnologies U.S.A. Inc
GlaxoSmithKline plc
Johnson & Johnson
Jubilant Pharmova Ltd
Lonza
Merck & Co. Inc
Novartis AG
Pfizer Inc
Samsung Biologics
Sanofi SA
Thermo Fisher Scientific Inc
Wuxi Apptec
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Molecule
Biologics & Biosimilars (Large Molecules)
-Monoclonal Antibodies
-Vaccines
-Cell & Gene Therapy
-Others
Conventional Drugs (Small Molecules)
By Drug Development
In-house
Outsource
By Formulation
Tablets
Capsules
Injectable
Sprays
Suspensions
Powders
Others
By Route of Administration
Oral
Topical
Parenteral
Inhalations
Others
By Therapy Area
Cardiovascular Diseases (CVDs)
Pain
Diabetes
Cancer
Respiratory Diseases
Others
By Prescription
Prescription Medicines
Over-the-counter (OTC) Medicines
By Age Group
Children & Adolescents
Adults
Geriatric
By Sales Channel
Retail
Non-retail